1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow AV-203: new trials by email Literature Review of AV-203 trials Research Report on AV-203
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors AV-203 - Solid Tumors | Phase 1 | Completed | AVEO Pharmaceuticals, Inc. | 24 | 2012-05-01 | 2015-04-08 |
AVEO Pharmaceuticals, Inc. (1)
United States (1)